The milestone comes only 19 days after the FDA granted market clearance to the device, CoNextions said May 16. The single-use implant consists of two stainless steel anchors implanted in either end of the injured tendon. The anchors are then connected by two looks of ultra-high-tenacity polyethylene yarn.
In the procedure, Dr. Young used the implant to repair the patient’s zone 2 flexor tendon in the little finger.
“After reviewing the data from CoNextions’ clinical trial, I felt confident that the CoNextions TR System was a better alternative to suture for my patient,” Dr. Young said in a news release. “I was also excited to see how much easier the device was to use compared to tying a complex suture knot that creates more bulk in the repaired tendon.”
